Zymar and Vioxx drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Zymar (gatifloxacin) and Vioxx (rofecoxib). Common drug interactions include abdominal distension among females and anxiety among males.

The phase IV clinical study analyzes what interactions people have when they take Zymar and Vioxx. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.

What is Zymar?

Zymar has active ingredients of gatifloxacin. eHealthMe is studying from 692 Zymar users. Check the latest studies of Zymar.

What is Vioxx?

Vioxx has active ingredients of rofecoxib. It is often used in arthritis. eHealthMe is studying from 110,130 Vioxx users. Check the latest studies of Vioxx.



On Jul, 06, 2026

18 people who take Zymar and Vioxx together, and have interactions are studied.

Zymar and Vioxx drug interactions.

What are the common drug interactions of Zymar and Vioxx, by gender? *:

female:

  1. Abdominal distension
  2. Abdominal pain upper
  3. Acute coronary syndrome (acute chest pain and other symptoms that happen because the heart does not get blood)
  4. Alopecia (absence of hair from areas of the body)
  5. Anaemia (lack of blood)
  6. Anaemia of malignant disease
  7. Anxiety
  8. Barrett's oesophagus (barrett's oesophagus is a disorder in which the lining of the oesophagus (the tube that carries food from the throat to the stomach) is damaged by stomach acid and changed to a lining similar to that of the stomach)
  9. Bone deformity
  10. Bone disorder

male:

  1. Anxiety
  2. Hypertension (high blood pressure)
  3. Osteomyelitis (infection of bone)
  4. Anaemia (lack of blood)
  5. Back pain
  6. Decreased appetite
  7. Fatigue (feeling of tiredness)
  8. Haemorrhoids (a swollen vein or group of veins in the region of the anus)
  9. Hyperglycaemia (high blood sugar)
  10. Leukocytosis (increased white blood cells)

What are the common drug interactions of Zymar and Vioxx, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Cardiac failure congestive
  2. Depression
  3. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)

50-59:

  1. Jaw fracture
  2. Osteomyelitis (infection of bone)
  3. Osteonecrosis (death of bone)
  4. Pain in jaw
  5. Pathological fracture (broken bone caused by disease)
  6. Speech disorder
  7. Tooth extraction
  8. Toothache (tooth pain)
  9. Blood cholesterol increased
  10. Cataract (clouding of the lens inside the eye)

60+:

  1. Arthralgia (joint pain)
  2. Back pain
  3. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  4. Dehydration (dryness resulting from the removal of water)
  5. Depression
  6. Fatigue (feeling of tiredness)
  7. Haemorrhoids (a swollen vein or group of veins in the region of the anus)
  8. Hyperlipidaemia (presence of excess lipids in the blood)
  9. Insomnia (sleeplessness)
  10. Muscular weakness (muscle weakness)

What are the existing conditions these people have? *

  1. Osteoarthritis (a joint disease caused by cartilage loss in a joint): 3 people, 16.67%
  2. High Blood Pressure: 3 people, 16.67%
  3. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 11.11%
  4. Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 1 person, 5.56%
  5. Heart Rate Irregular: 1 person, 5.56%
  6. Diabetic Gastroparesis (paralysis of the muscles of the stomach caused by diabetes): 1 person, 5.56%
  7. Depression: 1 person, 5.56%
  8. Bone Disorder: 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Zymar and Vioxx?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Zymar and Vioxx:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Zymar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Vioxx:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Zymar and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Vioxx and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on gatifloxacin and rofecoxib (the active ingredients of Zymar and Vioxx, respectively), and Zymar and Vioxx (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: